F. Bombaci

Considerations for Treatment‐free Remission in Patients With Chronic Myeloid Leukemia: A Joint Patient–Physician Perspective

G. Saglio, P. Westerweel, V. García-Gutiérrez, 2018, Clinical lymphoma, myeloma & leukemia.

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24

G. Abel, M. Sprangers, M. Baccarani, 2014, Quality of Life Research.

Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs

J. Geissler, Z. Pemberton-Whiteley, G. Sharf, 2020, Leukemia.

Clinical pathway for patients with Chronic Myeloid Leukaemia: The Euriclea Project

G. Artioli, C. Cosentino, F. Pane, 2017, Acta bio-medica : Atenei Parmensis.

Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries

J. Hasford, J. Geissler, V. Hoffmann, 2017, Journal of Cancer Research and Clinical Oncology.

Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial.

R. Larson, N. Takahashi, A. Hochhaus, 2022, Future oncology.